2-苯基戊-1-胺 | 104177-99-3

• 分子结构分类: 有机化合物 - 有机氮化合物
• 中文名称: 2-苯基戊-1-胺
• 英文名称: 2-Phenyl-pentylamine
• 英文别名: 2-Phenylpentan-1-amine
• CAS: 104177-99-3
• 化学式: C₁₁H₁₇N
• 分子量: 163.263
• InChiKey: SQMNYSQPHYHTSO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  12
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.45
• 拓扑面积：
  26
• 氢给体数：
  1
• 氢受体数：
  1

安全信息

• 海关编码：
  2921499090

反应信息

• 作为产物：
  描述：

  2-苯基-4-戊烯-1-胺 在 (1,3-bis(3′-butylimidazol-1-yl-2-idene)-2-phenylene)bis(tert-butylimido)tantalum(V) lithium iodide bridged dimer 作用下， 以 氘代甲苯 为溶剂， 反应 12.0h， 以50%的产率得到2-甲基-4-苯基吡咯烷
  参考文献：
  名称：

  极端的π负载作为获得亚氨基配体反应性的设计元素。CCC-NHC夹钳式钽双（亚氨基）配合物：烯烃的合成，表征和催化氧化胺化

  摘要：

  A rare Ta bis(imido) complex, which has unique reactivity, was prepared by manipulating the coordination sphere of a CCC-NHC pincer Ta complex. The reaction of lithium tert-butylamide with complex 1 yielded (1,3-bis(3'-butylimidazol-2'-yl-1'-idene)-2-phenylene)bis(tert-butylimido)tantalum(V) (2) as a lithium iodide bridged dimer, as determined by the X-ray structure. Complex 2 catalytically cyclized alpha,omega-aminoalkenes to effect an oxidative amination of alkenes (dehydrogenation by C-H activation) and produced a cyclic imine, an equivalent of reduced substrate, and varying proportions of hydroamination. Various additives and concentration impact the catalytic results. Computational and experimental observations have led to an initial mechanistic hypothesis. Based upon it, precatalyst 2 appears to be the first example of a bifunctional catalyst (MH-NHR) that is highly selective for nonpolar C-C bonds in preference to polar C-X bonds for outer-sphere hydrogenation.

  DOI：

  10.1021/acs.organomet.6b00216

文献信息

• [EN] HETEROARYL AMIDE ANALOGUES<br/>[FR] ANALOGUES D'HÉTÉROARYLAMIDES
  申请人：NEUROGEN CORP

  公开号：WO2009023623A1

  公开（公告）日：2009-02-19

  Compounds, pharmaceutical compositions, and methods of use are disclosed for heteroaryl amide analogues of formula Ia and/or Ib: . In certain embodiments, the heteroaryl amide analogues are agonists and/or ligands of dopamine receptors and may be useful, inter alia, for the treatment of a condition responsive to P2X7 receptor modulation, for example, pain, inflammation, a neurological or neurodegenerative disorder, a cardiovascular disorder, an ocular disorder or an immune system disorder.

  公开了公式Ia和/或Ib的杂环酰胺类似物的化合物、药物组合物和使用方法。在某些实施例中，这些杂环酰胺类似物是多巴胺受体的激动剂和/或配体，可能有助于治疗对P2X7受体调节敏感的疾病，例如疼痛、炎症、神经系统或神经退行性疾病、心血管疾病、眼部疾病或免疫系统疾病。
• Intramolecular Hydroamination of Unbiased and Functionalized Primary Aminoalkenes Catalyzed by a Rhodium Aminophosphine Complex
  作者：Lisa D. Julian、John F. Hartwig

  DOI：10.1021/ja1052126

  日期：2010.10.6

  We report a rhodium catalyst that exhibits high reactivity for the hydroamination of primary aminoalkenes that are unbiased toward cyclization and that possess functional groups incompatible with more electrophilic hydroamination catalysts. The rhodium catalyst contains an unusual diaminophosphine ligand (L1) that binds to rhodium in a κ(3)-P,O,P mode. The reactions catalyzed by this complex typically

  我们报告了一种铑催化剂，它对伯氨基烯烃的加氢胺化表现出高反应性，这些烯烃不偏向环化，并且具有与更多亲电加氢胺化催化剂不相容的官能团。铑催化剂含有一种不寻常的二氨基膦配体 (L1)，它以 κ(3)-P,O,P 模式与铑结合。由该配合物催化的反应通常在温和的温度（室温至 70°C）下进行，并且发生在烷基链上缺少取代基的伯氨基烯烃，使系统倾向于环化，伯氨基烯烃含有氯化物、酯、醚、可烯醇化的酮、腈和未保护的醇官能团，以及含有内烯烃的伯氨基烯烃。机理数据表明，这些反应发生的转换限制步骤不同于由 Pd、Pt 和 Ir 的后过渡金属配合物催化的反应。转化限制步骤的这种变化以及由此产生的催化剂的高活性源于 MC 键的质子分解以释放加氢胺化产物与氨基烷基中间体的回复以再生无环前体的有利相对速率。L1 的铑配合物的反应性起源的探针意味着氨基膦基团通过超出空间需求和简单的电子向金属中心的作用导致这些有利的速率。
• [EN] METHOD FOR PRODUCING AN OPTICALLY ACTIVE NITRO COMPOUND<br/>[FR] PROCEDE DE PRODUCTION D'UN COMPOSE NITRO OPTIQUEMENT ACTIF
  申请人：CARREIRA ERICK M

  公开号：WO2004103951A1

  公开（公告）日：2004-12-02

  An optically active nitro compound having two hydrogen atoms on its α-cabon atom and having β-asymmetric carbon atom can be produced by making α, β-unsaturated nitroolefin having a hydrogen atom on its α-cabon atom react with at least two organosilicon compounds having at lest one silicon-hydrogen bond in the molecule in the presence of an asymmetric copper complex, or react with an organosilicon compound having at least one silicon-hydrogen bond in the molecule in the presence of an asymmetric copper complex and water.

  具有两个氢原子的α-碳原子和β-手性碳原子的光学活性硝基化合物可以通过使具有α-碳原子上的氢原子的α，β-不饱和硝基烯烃与至少两个分子中至少有一个硅-氢键的有机硅化合物在存在不对称铜配合物的情况下反应，或者在存在不对称铜配合物和水的情况下，使具有至少一个硅-氢键的有机硅化合物与α-碳原子上的氢原子反应来制备。
• Method for producing an optically active nitro compound
  申请人：Carreira M. Erick

  公开号：US20070037976A1

  公开（公告）日：2007-02-15

  An optically active nitro compound having two hydrogen atoms on its α-cabon atom and having β-asymmetric carbon atom can be produced by making α, β-unsaturated nitroolefin having a hydrogen atom on its α-cabon atom react with at least two organosilicon compounds having at lest one silicon-hydrogen bond in the molecule in the presence of an asymmetric copper complex, or react with an organosilicon compound having at least one silicon-hydrogen bond in the molecule in the presence of an asymmetric copper complex and water.

  具有α-碳原子上两个氢原子和β-不对称碳原子的光学活性硝基化合物可以通过使具有α-碳原子上氢原子的α，β-不饱和硝基烯与至少两种分子中具有至少一个硅-氢键的有机硅化合物在不对称铜配合物存在下反应，或在不对称铜配合物和水存在下与具有至少一个硅-氢键的有机硅化合物反应而制得。
• Heteroaryl Amide Analogues
  申请人：Bakthavatchalam Rajagopal

  公开号：US20120190680A1

  公开（公告）日：2012-07-26

  Compounds, pharmaceutical compositions, and methods of use are disclosed for heteroaryl amide analogues of formula Ia and/or Ib: In certain embodiments, the heteroaryl amide analogues are agonists and/or ligands of dopamine receptors and may be useful, inter alia, for the treatment of a condition responsive to P2X 7 receptor modulation, for example, pain, inflammation, a neurological or neurodegenerative disorder, a cardiovascular disorder, an ocular disorder or an immune system disorder.

  本发明揭示了公式Ia和/或Ib的杂环酰胺类似物的化合物、制药组合物和使用方法：在某些实施例中，杂环酰胺类似物是多巴胺受体的激动剂和/或配体，可用于治疗对P2X7受体调节有反应的疾病，例如疼痛、炎症、神经或神经退行性疾病、心血管疾病、眼部疾病或免疫系统疾病等。